P/B
2,6
Inspire Medical Systems
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
$2.1B
Market Cap • 9/14/2026
2007
(19 years)
Founded
2018
(8 years ago)
IPO
NYSE
Listing Exchange
United States
Country
Valuation
P/S
2,4
P/EBITDA
30,1
P/OCF
13,7
P/FCF
18,4
P/E
16,1
BVPS
28,4
EPS
4,6
Market Cap
Market Cap
2,1B
EV
1,9B
EV/Revenue
2,1
EV/EBITDA
26
EV/EBIT
34,3
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
4,4%
Total Yield
4,4%
Payout
0%
Retained Earnings
-157,5M
Profitability
Gross Margin
86,1%
EBITDA Margin
7,9%
EBIT Margin
6%
Net Margin
15%
D&A/EBITDA
0%
R&D/Revenue
11,1%
Capex/Revenue
4,4%
Capex/D&A
232,4%
Capex/OCF
25,5%
SBC/OCF
76%
% PPE
13,7%
% Goodwill
0%
ROE
18%
ROIC
17,4%
Growth
CAGR Revenue 5Y
38,7%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
8,6
Quick Ratio
6
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!